Another method, topical formulations, acts topically on the skin
35.8%) [Figure 1.15]
An implantable neuroimmune modulation device for autoimmune disease Last year Peterson and colleagues published a randomized, double-blind, sham controlled trial of an implantable 1 inch device to stimulate the vagus nerve in 60 patients with rheumatoid arthritis to show feasability and safety
Emerging research is also investigating the broader systemic effects of GLP-1, GIP, and glucagon receptor agonists, including potential roles in: Metabolic dysfunction research Cardiometabolic health Inflammatory-response pathways Cellular stress and oxidative-stress pathways Neuroprotective and systemic health research Responses and tolerability may vary significantly between individuals depending on dosage, consistency, nutrition, lifestyle, stress, sleep, hormonal balance, and overall metabolic health